Guyana vs Sudan: Cause of death, by non-communicable diseases, ages 15-59, female
Guyana
53.6%
in 2021
Sudan
53.2%
in 2021
Guyana rank
119th
Sudan rank
122nd
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Guyana
- Sudan
How they compare
Guyana currently reports 53.6% against 53.2% in Sudan, a difference of 0.4%.
Across all 6 years both countries report, Guyana has been ahead every year.
Guyana ranks 119th and Sudan ranks 122nd of 185 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.6% | 42.1% | 21.5% | Guyana |
| 2010s | 66.4% | 54.4% | 12.0% | Guyana |
| 2020s | 59.6% | 54.7% | 5.0% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Guyana or Sudan?
- Guyana, at 53.6% against 53.2% in Sudan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Guyana and Sudan?
- 0.4%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Sudan?
- 6 years are reported by both, from 2000 to 2021.
- How do Guyana and Sudan rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Guyana ranks 119th and Sudan ranks 122nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.